Tempus AI congratulated the SERENA6 study team for their oncology trials.
Published
Signal category
Research & Knowledge
Quote
“Congrats to the SERENA6 study team.”
— Alan Tan, MD|Tempus AI team
Company
Tempus AI
Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine.
- Industry
- Biotechnology Research
- Location
- Chicago, US
- Company size
- 3,122 employees
Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating system to make that data accessible and useful, Tempus provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data. For more information, visit tempus.com.
Founded 2015